Clinical Trials Logo

Filter by:
NCT ID: NCT00219388 Completed - Heart Failure Clinical Trials

Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.

Start date: November 2002
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the effects of levosimendan with dobutamine on heart function in patients suffering of severe chronic heart failure.

NCT ID: NCT00219141 Completed - Hypertension Clinical Trials

Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension

ALLAY
Start date: October 2005
Phase: Phase 3
Study type: Interventional

To compare the efficacy and safety of aliskiren in combination with losartan compared to losartan on the regression of the increased size of the left ventricle in overweight patients with high blood pressure.

NCT ID: NCT00219102 Completed - Hypertension Clinical Trials

A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients

Start date: June 2005
Phase: Phase 3
Study type: Interventional

To evaluate the blood pressure lowering effect and safety of aliskiren used in combination with valsartan/hydrochlorothiazide in diabetic patients with essential hypertension, not adequately responsive to the combination of valsartan and hydrochlorothiazide

NCT ID: NCT00217763 Active, not recruiting - Alzheimer's Disease Clinical Trials

European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients

Start date: September 2005
Phase: Phase 3
Study type: Interventional

The purpose of this Phase 3 study is to evaluate the efficacy and safety of 3APS as an add-on therapy to most standard medication for Alzheimer's disease compared to placebo (inactive substance pill) in patients with mild to moderate Alzheimer's disease.

NCT ID: NCT00216944 Completed - Premature Birth Clinical Trials

Balanced Anesthesia for Intubation of Premature Infants

Start date: August 2005
Phase: Phase 4
Study type: Interventional

The study aim is to compare a balanced anesthesia of the medicines used in all other age groups with the routine premedication in use for premature's with regards to the success in the intubation procedure, the need for analgesia during and after intubation and the stress reaction. In addition a pain scale for prolonged stress/pain for premature neonates in NICU-care will be validated, and the individual pharmacogenetic profile in relation to the need of morphine after the intubation will be investigated. The hypothesis is that balanced anesthesia before intubation facilitates the procedure, decreases the amount of stress and pain related to it, and causes a decreased need for analgesia after the intubation.

NCT ID: NCT00216931 Withdrawn - Clinical trials for Respiratory Distress Syndrome

Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost

Start date: May 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if iloprost is effective in the treatment of elevated arterial pulmonary pressure in children with ventilator treated respiratory distress syndrome.

NCT ID: NCT00216827 Completed - Psoriasis of Scalp Clinical Trials

Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate whether once daily treatment for up to 8 weeks of calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) gel is safe and more effective than betamethasone 0.5 mg/g (as dipropionate) in the gel vehicle, calcipotriol 50 mcg/g in the gel vehicle or the gel vehicle used alone in patients with scalp psoriasis. The primary outcome is the proportion of patients with absence of disease or very mild disease after 8 weeks of treatment.

NCT ID: NCT00216671 Completed - Schizophrenia Clinical Trials

Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

Start date: November 2005
Phase: Phase 4
Study type: Interventional

The primary objective of this randomized trial was to investigate whether early initiation of treatment with Risperdal Consta after an acute episode was not inferior to the routine approach (oral treatment for 12 weeks followed by treatment with Risperdal Consta). .

NCT ID: NCT00216476 Completed - Schizophrenia Clinical Trials

A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate whether a long-acting injectable formulation of risperidone provides better effectiveness over 2 years, as measured by the time to relapse, compared with quetiapine tablets in a routine psychiatric care setting. Aripiprazole will be investigated in a descriptive manner.

NCT ID: NCT00214773 Completed - Clinical trials for Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)

Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)

Start date: July 2005
Phase:
Study type: Observational

The objectives of this program are: to further characterize the natural progression of MPS VI disease; to generate and disseminate information on the care and management of MPS VI patients to clinical and medical professionals; to provide a resource to physicians and patients by providing information for optimizing patient care based on aggregate data; to characterize the clinical response to long-term Naglazyme® (galsulfase) treatment; to further characterize the long-term safety of Naglazyme® treatment.